Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 801–900 of 1,001
ASPECTOS DA SUPLEMENTAÇÃO COM MIO-INOSITOL NA DIABETES MELLITUS GESTACIONAL: UMA REVISÃO INTEGRATIVA
de Vasconcelos, J. A., Fukushima, A. R., & Nicoletti, M. A. (2025) · Revista Foco · doi:10.54751/revistafoco.v18n1-040 · Cited by 21
Practical combination therapy based on pathophysiology of type 2 diabetes
LEVIN, P. A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s109216 · Cited by 21
Balani, J., Hyer, S. L., Syngelaki, A., Akolekar, R., Nicolaides, K. H., Johnson, A., & Shehata, H. A. (2017) · Obstetric Medicine · doi:10.1177/1753495x17725465 · Cited by 21
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study
Bauckneht, M., Cossu, V., Castellani, P., Piccioli, P., Orengo, A. M., Emionite, L., Giulio, F. D., Donegani, M. I., Miceli, A., Raffa, S., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.007 · Cited by 21
Ebrahimian, M. R., Tavakolian, M., & Hosseini‐Sarvari, M. (2023) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2023.109347 · Cited by 21
Karami, F., Jamaati, H., Coleman‐Fuller, N., Zeini, M. S., Hayes, A. W., Gholami, M., Salehirad, M., Darabi, M., & Motaghinejad, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00469-1 · Cited by 21
The development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
Lai, L., & Ghebremariam, Y. T. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1982096 · Cited by 21
Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma
Cheng, J. J. S., Li, H., Tan, H. S., Tan, P. H., Ng, L. G., Ng, Q. S., Toh, C., Kanesvaran, R., & Tan, M. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.12.012 · Cited by 21
Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study
Riera-Borrull, M., García‐Heredia, A., Fernández‐Arroyo, S., Hernández‐Aguilera, A., Cabré, N., Cuyàs, E., Luciano‐Mateo, F., Camps, J., Menéndez, J. A., & Joven, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112263 · Cited by 24
Biguanides enhance antifungal activity against Candida glabrata
Xu, S., Feliu, M., Lord, A. K., Lukason, D. P., Negoro, P. E., Khan, N. S., Dagher, Z., Feldman, M. B., Reedy, J. L., Steiger, S. N., et al. (2018) · Virulence · doi:10.1080/21505594.2018.1475798 · Cited by 24
Aldobeaban, S., Mzahim, B., & Alshehri, A. A. (2018) · Journal of Medical Case Reports · doi:10.1186/s13256-018-1758-0 · Cited by 23
Metformin attenuates cisplatin-induced genotoxicity and apoptosis in rat bone marrow cells
Cheki, M., Ghasemi, M. S., Rashnoudi, A. R., & Majd, N. E. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2019.1609024 · Cited by 21
Metformin in tuberculosis: beyond control of hyperglycemia
Oglesby, W., Kara, A. M., Granados, H., & Cervantes, J. (2019) · Infection · doi:10.1007/s15010-019-01322-5 · Cited by 25
Tseng, C. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819895159 · Cited by 22
Gu, C., Cheng, J., Zhang, B., Yang, S., Xie, F., Sun, J., Huang, L., Yu, J., & Li, M. (2017) · Europe PMC (PubMed Central) · Cited by 21
Muscle Disuse Atrophy Caused by Discord of Intracellular Signaling
Ji, L. L., Yeo, D., & Kang, C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8072 · Cited by 22
Amoani, B., Sakyi, S. A., Mantey, R., Laing, E. F., Ephraim, R. D., Sarfo-Kantanka, O., Koffie, S., Obese, E., & Afranie, B. O. (2021) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1862861 · Cited by 22
Pateliya, B., BURADE, V. S., & Goswami, S. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02104-3 · Cited by 21
Arum, O., Saleh, J. K., Boparai, R. K., Kopchick, J. J., Khardori, R. K., & Bartke, A. (2014) · AGE · doi:10.1007/s11357-014-9651-2 · Cited by 24
Metformin and Angiogenesis in Cancer - Revisited
Kannarkatt, J., Alkharabsheh, O. A., Tokala, H., & Dimitrov, N. V. (2016) · Oncology · doi:10.1159/000448175 · Cited by 24
Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?
Laskar, J., Bhattacharjee, K., Sengupta, M., & Choudhury, Y. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0402-z · Cited by 23
Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 23
Espe, M., Xie, S., Chen, S., Pedro, A., & Holen, E. (2019) · Aquaculture Nutrition · doi:10.1111/anu.12905 · Cited by 22
Gou, S., Qiu, L., Yang, Q., Li, P., Zhou, X., Sun, Y., Zhou, X., Zhao, W., Zhai, W., Li, G., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115523 · Cited by 21
Cozza, A., Chinigò, C., Filicetti, E., Greco, G. I., Lappano, R., Marinaro, C., Muglia, L., Soraci, L., Corsonello, A., Lattanzio, F., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102834 · Cited by 20
Uddin, J., Shah, S. W. A., Zahoor, M., Ullah, R., & Alotaibi, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22546 · Cited by 22
Zhang, J., Wu, J., He, Q., Liang, W., & He, J. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.03.14 · Cited by 20
Moeez, S., Riaz, S. K., Masood, N., Kanwal, N., Arif, M. A., Niazi, R., & Khalid, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.07.001 · Cited by 20
Metformin improves ovarian insulin signaling alterations caused by fetal programming
Heber, M. F., Ferreira, S. R., Abruzzese, G. A., Raices, T., Pignataro, O. P., Vega, M., & Motta, A. B. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0520 · Cited by 20
Calabash (Lagenaria siceraria) potency to ameliorate hyperglycemia and oxidative stress in diabetes
Juee, L. Y. M., & Naqishbandi, A. M. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103821 · Cited by 26
Lee, H. W., Lee, J. S., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107747 · Cited by 20
Tsakiridis, E. E., Broadfield, L. A., Marcinko, K., Biziotis, O., Ali, A., Mekhaeil, B., Ahmadi, E., Singh, K., Mesci, A., Zacharidis, P. G., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101209 · Cited by 22
Diri, H., Karaburgu, S., Açmaz, B., Ünlühızarcı, K., Tanrıverdi, F., Karaca, Z., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1080679 · Cited by 24
Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes
Adeshara, K. A., & Tupe, R. S. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3947-5 · Cited by 21
Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment
Oyaizu-Toramaru, T., Suhara, T., Hayakawa, N., Nakamura, T., Kubo, A., Minamishima, S., Yamaguchi, K., Hishiki, T., Morisaki, H., Suematsu, M., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-17 · Cited by 21
Peng, Y. H., Chang, Q., Yang, N., Gu, S., Zhou, Y., Yin, L., Aa, J., Wang, G., & Sun, J. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.02.007 · Cited by 20
Effects of Periodic Intensive Insulin Therapy: An Updated Review
Dong, S., Lau, H., Chavarria, C., Alexander, M., Cimler, A., Elliott, J. P., Escovar, S. X., Lewin, J., Novak, J., & Lakey, J. R. T. (2019) · Current Therapeutic Research · doi:10.1016/j.curtheres.2019.04.003 · Cited by 22
Sunagawa, Y., Shimizu, K., Katayama, A., Funamoto, M., Shimizu, K., Sari, N., Shimizu, S., Miyazaki, Y., Katanasaka, Y., Hasegawa, K., et al. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.07.001 · Cited by 20
Biomarker selection strategies based on compound stability in wastewater-based epidemiology
Gao, Z., Li, P., Lin, H., Lin, W., & Ren, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-24268-y · Cited by 19
Kemnade, J. O., Florez, M. A., Sabichi, A. L., Zhang, J., Jhaveri, P. M., Chen, G., Chen, A. C., Miller-Chism, C. N., Bulsara, S., Hilsenbeck, S. G., et al. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106536 · Cited by 19
Hong, X., Tai, X., Cheng, W., Wu, Y.-L. L. C., He, D., Wang, L., Liu, H., Zhang, S.-Y., Sun, Y., Liu, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87537-z · Cited by 19
Something old, something new and something very old: drugs for treating type 2 diabetes
Kaiser, D., & Oetjen, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12624 · Cited by 24
Alshammari, A., Iqbal, R., & Baksh, I. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_416_19 · Cited by 19
Kim, Y.-S., Choi, E.-A., Lee, J., Kim, Y., You, H., Han, Y.-E., Kim, H.-S., Bae, Y., Kang, H., & Kim, J. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.010 · Cited by 19
Gedawy, A., Al‐Salami, H., & Dass, C. R. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0102 · Cited by 19
Masato, A., Sandre, M., Antonini, A., & Bubacco, L. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210203162617 · Cited by 19
Tseng, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.578831 · Cited by 20
Consequences of Diabetes Mellitus in Bone Health: Traditional Review
Kumari, C., Yagoub, G., Ashfaque, M., Jawed, S., & Hamid, P. (2021) · Cureus · doi:10.7759/cureus.13820 · Cited by 25
Hoogstraten, C. A., Lyon, J. J., Smeitink, J. A. M., Rüssel, F. G. M., & Schirris, T. J. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000568 · Cited by 20
Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects
Jang, K., Chung, H., Yoon, J., Moon, S., Yoon, S. H., Yu, K., Kim, K., & Chung, J. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.699 · Cited by 19
Araújo, T. G., Oliveira, A. G., Vecina, J. F., Marin, R. M., Franco, E. S., Saad, M. J. A., & Maia, M. B. D. S. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2753-7 · Cited by 20
Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia
Alzoubi, K. H., Mhaidat, N. M., Obaid, E. A., & Khabour, O. F. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1158-3 · Cited by 18
Gut microbiota on cardiovascular diseases-a mini review on current evidence
Zhang, S., Li, J., Li, L., & Yuan, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1690411 · Cited by 18
Riboni-Verri, G., McMurran, C. E., Mukherjee, T., Daruwalla, C., Holland, J., Gautam, R., Chen, B. S., Cutting, E., Qian, W., MacManus, D. G., et al. (2025) · Trials · doi:10.1186/s13063-025-09254-2 · Cited by 21
Naghiaee, Y., Vakili, M., Mohammadi, M. R., Mohiti, A., & Mohiti-Ardakani, J. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100122 · Cited by 18
Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action
Motafeghi, F. S., Shahsavari, R., Mortazavi, P., Babaei, A., Mojaveri, P. S., Khojasteh, O. A., & Shokrzadeh, M. (2023) · Toxicology Research · doi:10.1093/toxres/tfad060 · Cited by 19
Anand, S., & Patel, T. (2024) · Discover Oncology · doi:10.1007/s12672-024-01662-1 · Cited by 21
Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Kumphune, S., Chattipakorn, S. C., & Chattipakorn, N. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320009 · Cited by 19
Cancer risks from diabetes therapies: Evaluating the evidence
Li, C., & Kong, D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.006 · Cited by 19
Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis.
Guo, Y., Yu, T., Yang, J., Zhang, T., Zhou, Y., He, F., Kurago, Z., Myssiorek, D. J., Wu, Y., Lee, P., et al. (2015) · PubMed · Cited by 19
Effect of turnip leaf and root extracts on renal function in diabetic rats
Taheri, M. M. H., Hosseini, M., Fard, M. H., Ghiravani, Z., Vazifeshenas-Darmiyan, K., Yousefi, S., & Ezi, S. (2016) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-016-0249-3 · Cited by 18
Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet
Bojková, B., Kajo, K., Kisková, T., Kubatka, P., Žúbor, P., Solár, P., Péč, M., & Adamkov, M. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000576 · Cited by 18
Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor
Moschetta, M. G., Leonel, C., MASCHIO, L. B., Borin, T. F., Gelaleti, G. B., Jardim‐Perassi, B. V., Ferreira, L. C., Sonehara, N. M., Carvalho, L. G. S., Hellmén, E., et al. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666181218164050 · Cited by 19
Kim, J., Hyun, H.-J., Choi, E.-A., Kim, Y., Bae, Y., & Kang, H. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01085-1 · Cited by 18
In Vitro Evaluation of Antidiabetic Potential of Cleistocalyx nervosum var. paniala Fruit Extract
Chukiatsiri, S., Wongsrangsap, N., Ratanabunyong, S., & Choowongkomon, K. (2022) · Plants · doi:10.3390/plants12010112 · Cited by 18
What is the phenotype of patients with gastrointestinal intolerance to metformin?
Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.05.005 · Cited by 23
The biguanide metformin alters phosphoproteomic profiling in mouse brain
Khang, R., Park, C., & Shin, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.029 · Cited by 18
Ren, C., Tazawa, K., Kawashima, N., Ohshima, R., Okada, Y., Wang, S., Yu, Z., Han, P., Ohsugi, Y., Katagiri, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643676 · Cited by 18
Arefin, A., & Gage, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054785 · Cited by 17
Metformin for preventing the progression of chronic kidney disease
El-Damanawi, R., Stanley, I. K., Staatz, C. E., Pascoe, E. M., Craig, J. C., Johnson, D. W., Mallett, A. J., Hawley, C. M., Milanzi, E., Hiemstra, T. F., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013414.pub2 · Cited by 25
Bo, Y., Zhao, J., Liu, C., & Yu, T. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03594-6 · Cited by 20
Cucchiari, D., Podestà, M. A., Merizzoli, E., Calvetta, A., Morenghi, E., Angelini, C., Ponticelli, C. E., & Badalamenti, S. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0836-2 · Cited by 19
CR, D. D. C. (2014) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000199 · Cited by 17
Leuthold, P., Schwab, M. G., Hofmann, U., Winter, S., Rausch, S., Pollak, M., Hennenlotter, J., Bedke, J., Schaeffeler, E., & Haag, M. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00199 · Cited by 18
Pharmaceutical Intervention of Aging
Qian, M., & Liu, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_15 · Cited by 19
Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
Tsogas, F. K., Majerczyk, D., & Hart, P. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020867 · Cited by 18
Das, B. K., Knott, R. M., & Gadad, P. C. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00193-8 · Cited by 21
Ossai, E. C., Madueke, C. A., Amadi, E. B., Ogugofor, M. O., Momoh, A. M., Okpala, C. O. R., Anosike, C. A., & NJOKU, O. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062852 · Cited by 17
Exploring the recent molecular targets for diabetes and associated complications
Gupta, A. K., Behl, T., Sehgal, A., Bhardwaj, S., Singh, S., Sharma, N., & Hafeez, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06294-0 · Cited by 18
Dia, M., Léon, C., Chanon, S., Bendridi, N., Gomez, L., Rieusset, J., Thibault, H., & Paillard, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073569 · Cited by 19
Nath, S. (2022) · BioMolecular Concepts · doi:10.1515/bmc-2022-0021 · Cited by 17
Yang, Z., Qiao, C., Jia, Q., Chen, Z., Wang, X., liu, X., Zhang, R., Pu, K., & Wang, Z. (2022) · Theranostics · doi:10.7150/thno.75837 · Cited by 17
Wang, N. F., Jue, T. R., Holst, J., & Gunter, J. H. (2022) · BJUI Compass · doi:10.1002/bco2.187 · Cited by 21
Wang, C., Liu, T., Wang, J., Cheng, C., Zhang, Z., Zhang, J., Huang, H., & Li, Y. (2023) · Discover Oncology · doi:10.1007/s12672-023-00689-0 · Cited by 17
ANTIOXIDANT AND HYPOGLYCEMIC EFFECTS OF CURCUMIN PYRAZOLE DERIVATIVES
Puneeth, H. R., & Chandrashekariah, S. A. (2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 17
Portela, L. V., Gnoatto, J. A., Brochier, A., Haas, C. B., de Assis, A. M., de Carvalho, A. K., Hansel, G., Zimmer, E. R., Oses, J. P., & Muller, A. P. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1496-7 · Cited by 17
Yang, S., Lv, Q., Luo, T., Liu, L., Gao, R., Chen, S., Peng, Y., Cheng, Q., & Li, Q. (2013) · Mediators of Inflammation · doi:10.1155/2013/429207 · Cited by 17
Carlson, N., Hommel, K., Olesen, J. B., Gerds, T. A., Soja, A., Vilsbøll, T., Kamper, A., Torp-Pedersen, C. T., & Gislason, G. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12764 · Cited by 18
Park, D. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00474 · Cited by 17
Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes
Caputo, V., Termine, A., Strafella, C., Giardina, E., & Cascella, R. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i5.155 · Cited by 18
Mayadunne, T., Saadati, S., Asmelash, D., Mason, T., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16418 · Cited by 17
Effects of Bitter Melon Saponin on the Glucose and Lipid Metabolism in HepG2 Cell and C. elegans
Bai, J., Zhu, Y. G., Li, J., Zhang, Y., Dong, Y., & Xiao, X. (2020) · Journal of Food Quality · doi:10.1155/2020/8860356 · Cited by 18
Sibiya, A., Al‐Ghanim, K. A., Govindarajan, M., Nicoletti, M., Павловна, С. Н., & Vaseeharan, B. (2023) · Fishes · doi:10.3390/fishes8070380 · Cited by 16
Mull, A. J., Berhanu, T. K., Roberts, N. W., & Heydemann, A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.007 · Cited by 16
Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers
White, B., Evison, A., Dombi, E., & Townley, H. E. (2017) · Nanotechnology Science and Applications · doi:10.2147/nsa.s148068 · Cited by 16
The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct
Long, L., Hu, X., Li, X., Zhou, D., Shi, Y., Wang, L., Zeng, H., Yu, X., & Zhou, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s240252 · Cited by 17
Wang, L., Tian, Y., Shang, Z., Zhang, B., Hua, X., & Yuan, X. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108763 · Cited by 16
Impact of diabetes on the increased risk of hepatic cancer: An updated review of biological aspects
Das, B. K., & Gadad, P. C. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100025 · Cited by 16
Investigation of insulin resistance through a multiorgan microfluidic organ-on-chip
Tanataweethum, N., Trang, A., Lee, C., Mehta, J., Patel, N., Cohen, R., & Bhushan, A. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac4611 · Cited by 16
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.